Mill Creek Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
+3,474
New +$1.14M 0.02% 123
2025
Q2
Sell
-488
Closed -$212K 266
2025
Q1
$212K Buy
+488
New +$196K 0.01% 247
2024
Q4
Sell
-485
Closed -$252K 264
2024
Q3
$252K Sell
485
-17
-3% -$9.08K 0.01% 218
2024
Q2
$272K Buy
502
+36
+8% +$19K 0.01% 220
2024
Q1
$242K Sell
466
-22
-5% -$10.9K 0.01% 214
2023
Q4
$230K Sell
488
-39
-7% -$18K 0.01% 217
2023
Q3
$229K Sell
527
-157
-23% -$71.2K 0.01% 202
2023
Q2
$304K Buy
684
+155
+29% +$71.5K 0.01% 195
2023
Q1
$243K Sell
529
-25
-5% -$11.9K 0.01% 209
2022
Q4
$284K Buy
+554
New +$281K 0.01% 183

Other funds holding ELV

Mill Creek Capital Advisors's ELV Position: Q1 2026 in Review

Mill Creek Capital Advisors opened a new position in Elevance Health (ELV) in Q1 2026: 3,474 shares worth $1.02M. The stake represents 0.02% of the portfolio and ranks #123 among its holdings. This is a return to the name: Mill Creek Capital Advisors previously reported a position in ELV as recently as Q1 2025.

Mill Creek Capital Advisors first reported a position in ELV in Q4 2022 and has held it in 10 quarters since. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Mill Creek Capital Advisors held 3,474 shares of Elevance Health worth $1.02M as of Q1 2026.
  • Elevance Health was a new Mill Creek Capital Advisors position in Q1 2026.
  • Elevance Health made up 0.02% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #123 holding.
  • Mill Creek Capital Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 10 quarters since.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.